Amgen and biochemist Bruce Alberts have created a new online journal, looking to reveal often hidden results in biomedicine - MedCity NewsMedCity News

"Often times there are hidden results in biomedicical journal publications, which can lead to retractions and even fraud. This happens most often when there are no outsiders to confirm results. For that reason, Amgen Inc. and biochemist Bruce Alberts are starting a new journal, F1000Research, aimed to address this problem with an open access online source. To kick things off, Amgen, which is seeding the publication, is demonstrating three replications of its studies in diabetes and neurodegenerative disease. The company hopes this will inspire other companies to do the same. The journal is aiming to allow both companies and academic scientists to share their replications so that others will be less likely to waste time following up on flawed findings, Sasha Kamb said, according to Science Magazine ..."